412 filings
Page 2 of 21
DEFA14A
NDRA
ENDRA Life Sciences Inc
25 Jul 23
Additional proxy soliciting materials
4:03pm
8-K
NDRA
ENDRA Life Sciences Inc
25 Jul 23
Other Events
4:02pm
8-K
NDRA
ENDRA Life Sciences Inc
6 Jul 23
ENDRA Life Sciences Announces Adjournment of
5:25pm
DEFA14A
NDRA
ENDRA Life Sciences Inc
6 Jul 23
Additional proxy soliciting materials
5:25pm
ARS
2022 FY
NDRA
ENDRA Life Sciences Inc
24 May 23
Annual report to shareholders
4:13pm
DEFA14A
NDRA
ENDRA Life Sciences Inc
24 May 23
Additional proxy soliciting materials
4:04pm
DEF 14A
NDRA
ENDRA Life Sciences Inc
Definitive proxy
24 May 23
4:03pm
4
NDRA
ENDRA Life Sciences Inc
22 May 23
ENDRA Life Sciences / Michael Milos Thornton ownership change
7:30am
10-Q
2023 Q1
NDRA
ENDRA Life Sciences Inc
Quarterly report
15 May 23
4:55pm
8-K
NDRA
ENDRA Life Sciences Inc
15 May 23
ENDRA Life Sciences Reports First Quarter 2023 Financial Results and Provides a Business Update
12:00am
4
NDRA
ENDRA Life Sciences Inc
3 May 23
ENDRA Life Sciences / ANTHONY DIGIANDOMENICO ownership change
4:07pm
8-K
NDRA
ENDRA Life Sciences Inc
2 May 23
ENDRA Life Sciences Announces Pricing of Upsized $4.5 Million Public Offering
4:16pm
424B5
NDRA
ENDRA Life Sciences Inc
28 Apr 23
Prospectus supplement for primary offering
4:51pm
S-1MEF
NDRA
ENDRA Life Sciences Inc
28 Apr 23
Registration of additional securities for an S-1
6:07am
EFFECT
NDRA
ENDRA Life Sciences Inc
28 Apr 23
Notice of effectiveness
12:15am
CORRESP
NDRA
ENDRA Life Sciences Inc
24 Apr 23
Correspondence with SEC
12:00am
CORRESP
NDRA
ENDRA Life Sciences Inc
24 Apr 23
Correspondence with SEC
12:00am
S-1/A
NDRA
ENDRA Life Sciences Inc
IPO registration (amended)
18 Apr 23
9:39pm
8-K
NDRA
ENDRA Life Sciences Inc
18 Apr 23
Recent Financial Results
9:09am
S-1/A
NDRA
ENDRA Life Sciences Inc
IPO registration (amended)
18 Apr 23
9:06am